tem | $75,000,000 | (Feb 11, 2026)
Garner Health | $118,000,000 | (Feb 11, 2026)
NATILUS | $28,000,000 | (Feb 11, 2026)
Certified by Founder
Lodge
Infinitopes
start up
United Kingdom
- Oxford, Oxfordshire
- 21/01/2026
- Seed
- $15,400,000
Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival.
- Industry Biotechnology Research
- Website https://www.infinitopes.com/
- LinkedIn https://www.linkedin.com/company/infinitopes/
Related People
Senthil ChinnakannanCo Founder
United Kingdom -
Oxford, England
Molecular virologist/vaccinologist with expertise in multiple antigen/epitope vaccine design for Adeno/MVA viral vectors, passionate about translational research. Interests: Adeno/MVA viral vectors, therapeutic hepatitis B vaccine, prophylactic hepatitis C vaccine, therapeutic cancer vaccine
Entire | $60,000,000 | (Feb 11, 2026)
ZeroDrift | $2,000,000 | (Feb 11, 2026)
Force Equals | $2,200,000 | (Feb 11, 2026)
Bretton AI | $75,000,000 | (Feb 11, 2026)
Pelgo | $5,500,000 | (Feb 11, 2026)
BotGauge AI | $2,000,000 | (Feb 10, 2026)
microsynetics GmbH | $10,000,000 | (Feb 10, 2026)
Modveon | $10,000,000 | (Feb 10, 2026)